Professor Marcelle Machluf was named Lady Globes magazine’s “Woman of the Year” for 2018, and her work has been included in the Israel Ministry of Science and Technology’s list of “Israel’s 60 Most Impactful Developments.” The dean of the Technion Faculty of Biotechnology and Food Engineering, she is renowned for her cutting-edge cancer and drug delivery research, and her work in tissue regeneration.
She is head of the Technion’s graduate Interdisciplinary Program in Biotechnology, a member of the Affiliate Engineering Faculty of the Technion Integrated Cancer Center, and former deputy executive vice president for research for the Technion’s Pre-Clinical Research Authority. She also works closely with the Russell Berrie Nanotechnology Institute.
Prof. Machluf is developing a targeted drug delivery system using modified stem cells called Nano-Ghosts to home in on tumors, unleashing its therapeutic load at the cancer site. She is also developing scaffolding for tissue engineering of the pancreas, heart, and blood vessels, and developing carriers for cell delivery with applications for treating diabetes and more. She also has a laboratory at Nanyang Technological University of Singapore, where she is working on a leading tissue regenerative project.
Prof. Machluf has authored book chapters and more than 80 peer-reviewed journal papers in leading journals. Her work has been cited more than 2,800 times. She has six national patents and two approved international patents in the fields of drug delivery and tissue engineering. She is the recipient of many honors including the Alon Award for excellence in science, the Gutwirth Award for achievements in gene therapy, the Hershel Rich Technion Innovation Award, and the Juludan Research Prize for outstanding research.